173 related articles for article (PubMed ID: 36119051)
1. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer.
Takahashi K; Kurashina K; Yamaguchi H; Kanamaru R; Ohzawa H; Miyato H; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
Front Immunol; 2022; 13():969468. PubMed ID: 36119051
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry-based analysis of tumor-leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer.
Takahashi K; Kurashina K; Saito S; Kanamaru R; Ohzawa H; Yamaguchi H; Miyato H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Cytometry B Clin Cytom; 2021 Nov; 100(6):666-675. PubMed ID: 33277773
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Cytometry B Clin Cytom; 2014 Jan; 86(1):56-62. PubMed ID: 24115348
[TBL] [Abstract][Full Text] [Related]
4. Flow Cytometric Quantification of Intraperitoneal Free Tumor Cells is a Useful Biomarker in Gastric Cancer Patients with Peritoneal Metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Onoyama H; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Ann Surg Oncol; 2015 Jul; 22(7):2336-42. PubMed ID: 25404476
[TBL] [Abstract][Full Text] [Related]
5. Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer.
Fujimori D; Kinoshita J; Yamaguchi T; Nakamura Y; Gunjigake K; Ohama T; Sato K; Yamamoto M; Tsukamoto T; Nomura S; Ohta T; Fushida S
BMC Cancer; 2020 Oct; 20(1):1014. PubMed ID: 33081727
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric quantification of intraperitoneal free tumor cells (FTC) in patients with peritoneal metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Cytometry B Clin Cytom; 2013 Aug; ():. PubMed ID: 24038963
[TBL] [Abstract][Full Text] [Related]
7. Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer.
Peng LS; Mao FY; Zhao YL; Wang TT; Chen N; Zhang JY; Cheng P; Li WH; Lv YP; Teng YS; Guo G; Luo P; Chen W; Zou QM; Zhuang Y
Oncotarget; 2016 Aug; 7(34):55222-55230. PubMed ID: 27409423
[TBL] [Abstract][Full Text] [Related]
8. The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy.
van Baal JOAM; Lok CAR; Jordanova ES; Horlings H; van Driel WJ; Amant FC; Van de Vijver KK
Virchows Arch; 2020 Oct; 477(4):535-544. PubMed ID: 32179982
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast.
Nakamura Y; Kinoshita J; Yamaguchi T; Aoki T; Saito H; Hamabe-Horiike T; Harada S; Nomura S; Inaki N; Fushida S
Gastric Cancer; 2022 May; 25(3):515-526. PubMed ID: 34997450
[TBL] [Abstract][Full Text] [Related]
10. Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis.
Li Y; Jiang L; Chen Y; Li Y; Yuan J; Lu J; Zhang Z; Liu S; Feng X; Xiong J; Jiang Y; Zhang X; Li J; Shen L
Gastric Cancer; 2024 May; 27(3):519-538. PubMed ID: 38460015
[TBL] [Abstract][Full Text] [Related]
11. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
[TBL] [Abstract][Full Text] [Related]
12. High CD8/CD33 ratio in peritoneal metastatic lesions is associated with favorable prognosis in gastric cancer.
Yamaguchi T; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Makino I; Nakamura K; Tajima H; Ninomiya I; Fushida S
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1389. PubMed ID: 33793095
[TBL] [Abstract][Full Text] [Related]
13. Effect of Systemic or Intraperitoneal Administration of Anti-PD-1 Antibody for Peritoneal Metastases from Gastric Cancer.
Kumagai Y; Futoh Y; Miyato H; Ohzawa H; Yamaguchi H; Saito S; Kurashina K; Hosoya Y; Lefor AK; Sata N; Kitayama J
In Vivo; 2022; 36(3):1126-1135. PubMed ID: 35478147
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
15. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
[TBL] [Abstract][Full Text] [Related]
16. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
17. [The role of intraperitoneal macrophages in the progression of peritoneal carcinomatosis from gastric cancer].
Yamaguchi T; Fushida S; Tsukada T; Kinoshita J; Oyama K; Watanabe T; Okamoto K; Nakamura K; Ninomiya I; Fujimura T; Ohta T
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1270-2. PubMed ID: 25335714
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation.
Ito A; Kagawa S; Sakamoto S; Kuwada K; Kajioka H; Yoshimoto M; Kikuchi S; Kuroda S; Yoshida R; Tazawa H; Fujiwara T
BMC Cancer; 2021 Jan; 21(1):102. PubMed ID: 33509150
[TBL] [Abstract][Full Text] [Related]
19. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
[Next] [New Search]